Trials / Completed
CompletedNCT01924676
Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Food on Oxycodone Pharmacokinetics Following Oral 40 Mg Doses of PF-00345439 Formulation K and to Estimate Its Relative Bioavailability of Oxycodone Compared to PF-003454390 Formulation X in the Fasted State in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Pain Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers
Detailed description
This study will estimate the effect of food (standard high-fat breakfast) on the pharmacokineticsand relative bioavailability of oxycodone following oral administration of single 40 mg doses of PF-00345439 Formulation K in healthy volunteers. Additionally, the study will estimate the pharmacokinetics and relative bioavailability of oxycodone following oral administration of single 40 mg doses of the test PF-00345439 Formulation K compared with the reference PF-00345439 Formulation X under fasted conditions in healthy volunteers and assess the single-dose safety and tolerability of oxycodone in PF-00345439 formulations in healthy volunteers when administered under a naltrexone block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | One capsule of 40 mg PF-00345439 Formulation X, single dose, under fasting conditions |
| DRUG | Oxycodone | One capsule of 40 mg PF-00345439 Formulation K, single dose, under fasting conditions |
| DRUG | Oxycodone | One capsule of 40 mg PF-00345439 Formulation K, single dose, under fed conditions |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-08-16
- Last updated
- 2015-08-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01924676. Inclusion in this directory is not an endorsement.